The 2024 Onco-Nephrology Symposium welcomes all members of the healthcare team who manage patients with both cancer and kidney disease. This year's program embraces the multidisciplinary nature of onco-nephrology and features experts in plasma cell disorders such as multiple myeloma, amyloidosis, monoclonal gammopathies as well as renowned speakers on CAR T cell, other biologic therapies, thrombotic microangiopathy, and cardio-renal syndromes.
The goal of this forum is to allow academicians, clinicians, and clinical experts to have personal exchanges and robust discussions in order to enhance the clinical experiences and outcomes of patients.
1.
Screening tests that are non-invasive show promise in detecting colorectal cancer.
2.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
3.
The top three drugs for multiple myeloma treatment upfront are four.
4.
Taking vitamin D daily decreased cancer mortality, according to a study.
5.
New imaging technique identifies glioblastoma patients who would benefit from immunotherapy
1.
Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer
2.
The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective
3.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
Recommended News For You
1.
Treating advanced prostate cancer
2.
When performed by skilled surgeons, robotic surgery for pancreatic tumors is safe and feasible.
3.
Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation
4.
Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image
5.
Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma
Conferences That Might Interest You
Recommended Articles For You
1.
Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies
2.
Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence
3.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
4.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
5.
Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance
Boost Your Knowledge With These Quizzes
1.
Quiz on Gestational Diabetes: A Comprehensive Quiz on Causes, Risk Factors, Symptoms, and Management Strategies. Perfect for Expecting Parents and Healthcare Professionals Looking to Enhance Their Understanding of This Condition and Its Impact on Maternal
2.
Quiz on Intraoperative Radiation Therapy (IORT): Transforming Cancer Care in Real-Time
3.
Quiz On Nutrition Of Critically Ill Patients
4.
Quiz on Innovations in Radiotherapy: How does Stereotactic Body Radiotherapy (SBRT) improve treatment efficacy?
5.
Quiz on Snake Bites
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation